Market Overview:
The global orthopedic soft tissue repair devices market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of sports injuries, rising geriatric population, and technological advancements in soft tissue repair devices. Based on type, the global orthopedic soft tissue repair devices market is segmented into cell therapy, tissue scaffold, and fixation devices. Cell therapy is further sub-segmented into autologous cells and allogeneic cells. Tissue scaffold is further sub-segmented into natural materials and synthetic materials. Fixation devices are further sub-segmented into screws, plates & nails, wires & cables, sutures & staples,. Based on application, the global orthopedic soft tissue repair devices market is segmented into hospitals and clinics; ambulatory surgical centers (ASCs); physician’s office; research institutes; and others (including military camps).
Product Definition:
Orthopedic soft tissue repair devices are medical devices used to surgically repair musculoskeletal injuries. Orthopedic soft tissue repair devices are used to stabilize, align, and support injured muscles, tendons, and ligaments. Orthopedic soft tissue repair devices may also be used to promote healing of the injured tissues.
Cell therapy:
Orthopedic soft tissue repair devices are used to treat damaged bones, cartilage and joints. The main aim of these surgeries is to replace or restore the function of damaged tissues. Orthopedic soft tissue repair devices market is expected to witness lucrative growth over the forecast period owing to factors such as increasing geriatric population base, rising prevalence of joint injuries and obesity coupled with growing healthcare awareness among people across the globe especially in developing countries like India and China.
Tissue scaffold:
Tissue scaffold is a biological material that has the ability to stimulate new bone formation when used inside the body. It is widely used in orthopedic surgeries for repairing damaged bones and cartilages. The most commonly utilized type of tissue scaffold are allografts, which are taken from an animal source such as bovine or porcine sources.
Application Insights:
The market is segmented by application into hospitals and clinics, ASCs, and physician's office based on location. In 2017, the hospital and clinic based held the largest share of over 70.0% in North America. The primary factor contributing to this large share is that most orthopedic surgeons perform these procedures at hospitals or clinics where they have easy access to all types of advanced equipment needed for a successful outcome.
In addition, many insurance companies cover the cost of these surgeries in case they are performed at an accredited medical facility or hospital which further drives its demand from hospitals and clinics around the world especially in developed regions such as North America where healthcare facilities are equipped with latest technology required for better results after surgery.
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in the prevalence of orthopedic disorders coupled with high healthcare expenditure and favorable reimbursement policies. According to an article published by The Joint Commission, Inc., every year more than 1 million people are admitted to hospitals due to injuries related to osteoporosis fractures. Thus, increasing number of orthopedic procedures is anticipatedtohavea positive impact on the growth of this regional segment over the forecast period.
Asia Pacific region is expected toraise during the forecast period owing its abundant supply of raw material and low cost labor force.
Growth Factors:
- Increasing incidence of sports injuries and musculoskeletal disorders
- Growing geriatric population and their rising demand for orthopedic soft tissue repair devices
- Rising healthcare expenditure and improving insurance coverage for orthopedic soft tissue repair devices
- Technological advancements in orthopedic soft tissue repair devices industry
- Growing popularity of minimally invasive surgical procedures
Scope Of The Report
Report Attributes
Report Details
Report Title
Orthopedic Soft Tissue Repair Devices Market Research Report
By Type
Cell therapy, Tissue scaffold, Fixation devices
By Application
Hospitals and clinics, Ambulatory surgical centers (ASCs), Physician’s office
By Companies
Arthrex, Stryker, Zimmer Biomet, AlloSource, RepliCel, Orteq, CellGenix, Collagen Solutions, Vericel Corporation, BioTissue, Geistlich, Tornier, XTANT MEDICAL, TEIJIN, Parcus Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Orthopedic Soft Tissue Repair Devices Market Report Segments:
The global Orthopedic Soft Tissue Repair Devices market is segmented on the basis of:
Types
Cell therapy, Tissue scaffold, Fixation devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and clinics, Ambulatory surgical centers (ASCs), Physician’s office
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Arthrex
- Stryker
- Zimmer Biomet
- AlloSource
- RepliCel
- Orteq
- CellGenix
- Collagen Solutions
- Vericel Corporation
- BioTissue
- Geistlich
- Tornier
- XTANT MEDICAL
- TEIJIN
- Parcus Medical
Highlights of The Orthopedic Soft Tissue Repair Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cell therapy
- Tissue scaffold
- Fixation devices
- By Application:
- Hospitals and clinics
- Ambulatory surgical centers (ASCs)
- Physician’s office
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Orthopedic Soft Tissue Repair Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Orthopedic soft tissue repair devices are medical devices that are used to help heal and restore damaged or injured tissues in the body. These devices can be used to treat a variety of injuries, including tears, sprains, strains, and fractures.
Some of the major players in the orthopedic soft tissue repair devices market are Arthrex, Stryker, Zimmer Biomet, AlloSource, RepliCel, Orteq, CellGenix, Collagen Solutions, Vericel Corporation, BioTissue, Geistlich, Tornier, XTANT MEDICAL, TEIJIN, Parcus Medical.
The orthopedic soft tissue repair devices market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Orthopedic Soft Tissue Repair Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Orthopedic Soft Tissue Repair Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Orthopedic Soft Tissue Repair Devices Market - Supply Chain
4.5. Global Orthopedic Soft Tissue Repair Devices Market Forecast
4.5.1. Orthopedic Soft Tissue Repair Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Orthopedic Soft Tissue Repair Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Orthopedic Soft Tissue Repair Devices Market Absolute $ Opportunity
5. Global Orthopedic Soft Tissue Repair Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Orthopedic Soft Tissue Repair Devices Market Size and Volume Forecast by Type
5.3.1. Cell therapy
5.3.2. Tissue scaffold
5.3.3. Fixation devices
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Orthopedic Soft Tissue Repair Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Orthopedic Soft Tissue Repair Devices Market Size and Volume Forecast by Application
6.3.1. Hospitals and clinics
6.3.2. Ambulatory surgical centers (ASCs)
6.3.3. Physicians office
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Orthopedic Soft Tissue Repair Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Orthopedic Soft Tissue Repair Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Orthopedic Soft Tissue Repair Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Orthopedic Soft Tissue Repair Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Orthopedic Soft Tissue Repair Devices Demand Share Forecast, 2019-2026
9. North America Orthopedic Soft Tissue Repair Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Orthopedic Soft Tissue Repair Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Orthopedic Soft Tissue Repair Devices Market Size and Volume Forecast by Application
9.4.1. Hospitals and clinics
9.4.2. Ambulatory surgical centers (ASCs)
9.4.3. Physicians office
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Orthopedic Soft Tissue Repair Devices Market Size and Volume Forecast by Type
9.7.1. Cell therapy
9.7.2. Tissue scaffold
9.7.3. Fixation devices
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Orthopedic Soft Tissue Repair Devices Demand Share Forecast, 2019-2026
10. Latin America Orthopedic Soft Tissue Repair Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Orthopedic Soft Tissue Repair Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Orthopedic Soft Tissue Repair Devices Market Size and Volume Forecast by Application
10.4.1. Hospitals and clinics
10.4.2. Ambulatory surgical centers (ASCs)
10.4.3. Physicians office
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Orthopedic Soft Tissue Repair Devices Market Size and Volume Forecast by Type
10.7.1. Cell therapy
10.7.2. Tissue scaffold
10.7.3. Fixation devices
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Orthopedic Soft Tissue Repair Devices Demand Share Forecast, 2019-2026
11. Europe Orthopedic Soft Tissue Repair Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Orthopedic Soft Tissue Repair Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Orthopedic Soft Tissue Repair Devices Market Size and Volume Forecast by Application
11.4.1. Hospitals and clinics
11.4.2. Ambulatory surgical centers (ASCs)
11.4.3. Physicians office
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Orthopedic Soft Tissue Repair Devices Market Size and Volume Forecast by Type
11.7.1. Cell therapy
11.7.2. Tissue scaffold
11.7.3. Fixation devices
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Orthopedic Soft Tissue Repair Devices Demand Share, 2019-2026
12. Asia Pacific Orthopedic Soft Tissue Repair Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Orthopedic Soft Tissue Repair Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Orthopedic Soft Tissue Repair Devices Market Size and Volume Forecast by Application
12.4.1. Hospitals and clinics
12.4.2. Ambulatory surgical centers (ASCs)
12.4.3. Physicians office
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Orthopedic Soft Tissue Repair Devices Market Size and Volume Forecast by Type
12.7.1. Cell therapy
12.7.2. Tissue scaffold
12.7.3. Fixation devices
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Orthopedic Soft Tissue Repair Devices Demand Share, 2019-2026
13. Middle East & Africa Orthopedic Soft Tissue Repair Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Orthopedic Soft Tissue Repair Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Orthopedic Soft Tissue Repair Devices Market Size and Volume Forecast by Application
13.4.1. Hospitals and clinics
13.4.2. Ambulatory surgical centers (ASCs)
13.4.3. Physicians office
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Orthopedic Soft Tissue Repair Devices Market Size and Volume Forecast by Type
13.7.1. Cell therapy
13.7.2. Tissue scaffold
13.7.3. Fixation devices
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Orthopedic Soft Tissue Repair Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Orthopedic Soft Tissue Repair Devices Market: Market Share Analysis
14.2. Orthopedic Soft Tissue Repair Devices Distributors and Customers
14.3. Orthopedic Soft Tissue Repair Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Arthrex
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Stryker
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Zimmer Biomet
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. AlloSource
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. RepliCel
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Orteq
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. CellGenix
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Collagen Solutions
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Vericel Corporation
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. BioTissue
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Geistlich
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Tornier
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. XTANT MEDICAL
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. TEIJIN
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Parcus Medical
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
